FREQ:CA:TSV-Frequency Exchange Corp. (CAD)

COMMON STOCK | Medical Devices |

Last Closing

USD 0.25

Change

0.00 (0.00)%

Market Cap

USD 0.01B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Frequency Exchange Corp. focuses on the development and commercialization of a wearable frequency delivery system for the health and wellness market. The company is headquartered in Vancouver, Canada. Frequency Exchange Corp. is a subsidiary of Waveforce Electronics Inc.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
TLT:CA Theralase Technologies Inc.

-0.01 (-1.64%)

USD 0.07B
PINK:CA Perimeter Medical Imaging AI I..

+0.03 (+6.02%)

USD 0.05B
ASG:CA Aurora Spine Corp

+0.01 (+2.13%)

USD 0.03B
MDX:CA MedX Health Corp

N/A

USD 0.02B
NGMD:CA NuGen Medical Devices Inc

N/A

USD 0.02B
VPT:CA VentriPoint Diagnostics Ltd

+0.01 (+4.76%)

USD 0.02B
THRM:CA Therma Bright Inc

-0.01 (-12.50%)

USD 0.01B
EVMT:CA Evome Medical Technologies Inc..

+0.01 (+3.45%)

USD 0.01B
CNVI:CA Conavi Medical Corp.

-0.05 (-7.35%)

N/A

ETFs Containing FREQ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.28% 78% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.28% 78% C+ 71% C-
Trailing 12 Months  
Capital Gain 31.58% 63% D 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.58% 63% D 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 29.48% 63% D 75% C
Dividend Return 29.48% 63% D 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 88.58% 50% F 33% F
Risk Adjusted Return 33.28% 88% B+ 83% B
Market Capitalization 0.01B 11% F 58% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.